New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™

Data ReadoutpositiveAdvanceAD-Tx™Positive

AI Analysis

Summary

Study data demonstrates clinical need for molecular guidance in atopic dermatitis treatment selection, with 94% of surveyed patients interested in molecular testing and over half having modified systemic therapies due to lack of efficacy, supporting the value proposition of AdvanceAD-Tx™.

Outcome Details

Study showed 94% of patients open to new systemic therapy expressed interest in molecular testing; over half of patients using targeted systemic therapies modified treatment due to lack of efficacy

Importance:5/10

Sentiment:

0.60

atopic dermatitismolecular testingsystemic therapyclinical studydiagnostic test

Related Companies

$MOLN

Read the original article

Published by PR Newswire Biotech on September 24, 2026 8:30 PM

Read Original